DaVita Q1 2026 Earnings Strong EPS Beat Drives Positive Momentum TWFG Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates ABUS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline VRDN Q1 2026 Earnings NarrowerthanExpected Loss as Viridian Advances Clinical Pipeline POCI Q1 2026 Earnings Narrow Loss Amid Quiet Quarter Revenue Data Not Disclosed